1. 314 Injection site reactions from an integrated analysis of phase 2 and phase 3 clinical trials of lebrikizumab treatment in moderate-to-severe atopic dermatitis. (25th January 2023) Authors: Gooderham, Melinda; Shi, Vivian Y; Wollenberg, Andreas; Thyssen, Jacob P; Torres, Tiago; Gil, Esther Garcia; Bardolet, Laia; Natalie, Chitra R; Atwater, Amber R; Zhao, Fangyi; Blauvelt, Andrew Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗